Literature DB >> 1962621

Acute effects of abdominopelvic irradiation on the orocecal transit time: its relation to clinical symptoms, and bile salt and lactose malabsorption.

F Fernández-Bañares1, S Villá, M Esteve, M Roca, E Cabré, A Abad-Lacruz, J Martín-Comín, M A Gassull.   

Abstract

Twenty-five patients with abdominopelvic malignant tumors receiving irradiation were studied. The following items were assessed before, during, and at the end of the radiation period: 1) clinical symptoms, scored on the basis of their severity; 2) orocecal transit time (lactulose-H2 breath test); and 3) absorption of lactose and bile salts. Ninety-two percent of the patients showed clinical symptoms suggestive of acute radiation enteropathy, mainly diarrhea. A significant acceleration of the orocecal transit was observed during the study: 70 +/- 6.9 min vs 63.3 +/- 6.3 min vs 44.3 +/- 5.1 min (F = 5.49, p = 0.008), being faster in patients with severe diarrhea (F = 3.25, p = 0.05). Forty-four percent and 57% of the patients developed lactose and bile salt malabsorption, respectively. A decrease in the transit time was observed, independent of the absorption or malabsorption of such substances. However, the orocecal transit was faster in those lactose malabsorbers with severe diarrhea, than in those with mild diarrhea (F = 4.2, p = 0.03). The results suggest that acceleration of orocecal transit may be a major factor in the pathophysiology of radiation-induced diarrhea, whereas lactose malabsorption may contribute to the severity of the diarrhea.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1962621

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Performing the 75SeHCAT test using a collimated gamma camera.

Authors:  J Martin-Comin; P A de Lima Ramos
Journal:  Eur J Nucl Med       Date:  1996-06

Review 2.  [Prevention and therapy of acute radiation-related morbidity of the skin and mucosa. II, Recommendations of the literature].

Authors:  J S Zimmermann; P Niehoff; R Wilhelm; R Schneider; G Kovács; B Kimmig
Journal:  Strahlenther Onkol       Date:  1998-04       Impact factor: 3.621

Review 3.  Gastrointestinal problems in the immunosuppressed patient.

Authors:  V Aggarwal; M D Williams; S V Beath
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

4.  Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea.

Authors:  F Fernandez-Bañares; M Esteve; A Salas; T M Forné; J C Espinos; J Martín-Comin; J M Viver
Journal:  Dig Dis Sci       Date:  2001-10       Impact factor: 3.199

5.  Gastrointestinal and nutritional sequelae of bone marrow transplantation.

Authors:  A Papadopoulou; D R Lloyd; M D Williams; P J Darbyshire; I W Booth
Journal:  Arch Dis Child       Date:  1996-09       Impact factor: 3.791

Review 6.  Gut microbiota and inflammation.

Authors:  Asa Hakansson; Goran Molin
Journal:  Nutrients       Date:  2011-06-03       Impact factor: 5.717

Review 7.  Tumor-related dysmotility: gastrointestinal dysmotility syndromes associated with tumors.

Authors:  J K DiBaise; E M Quigley
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.487

8.  Randomised clinical trial of a gastrointestinal care bundle to reduce symptoms in patients with pelvic cancer undergoing chemoradiotherapy.

Authors:  Katherine L White; Caroline C Henson; Mark Hann; Martin Eden; Sorrel T Burden; Simon Lal; Susan E Davidson; John T McLaughlin
Journal:  BMJ Open Gastroenterol       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.